CurrentEndo coverage · page 16 of 33
Cardiovascular Diabetology
Latest from Cardiovascular Diabetology
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Association of estimated glucose disposal rate with metabolic syndrome prevalence and mortality risks: a population-based study
Cross-sectional studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Diabetes mellitus risk in post-myocardial infarction patients: FINDRISC versus self-assessment—a cross sectional study
Cross-sectional studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation
Cross-sectional studyLipids & liver
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol
Longitudinal changes in remnant cholesterol and the risk of cardiovascular disease
Cohort studyT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies
Cross-sectional studyT2D & other
Cardiovasc Diabetol